The CEO/CFO's concentrated buying over a short window suggests management sees value at current levels. Monitor for upcoming clinical or regulatory catalysts (e.g., FDA updates on GP2 vaccine trial) that could drive near-term upside. The small absolute size limits the signal's strength, but the pattern is worth watching.
Price Chart
Executive Summary
Greenwich LifeSciences CEO/CFO Snehal Patel purchased $88K of GLSI shares on the open market over four days (July 23-28, 2026) at an average price of ~$13.30. While the dollar amount is modest relative to the $188M market cap (0.05%), the consistent buying by the top executive signals insider conviction ahead of potential catalysts.
Key Financial Metrics
Key Facts
- CEO/CFO Snehal Patel purchased 6,600 shares total for $88K across four open-market transactions (July 23-28).
- Purchases occurred at prices ranging from $12.88 to $13.62 per share.
- The $88K represents approximately 0.05% of GLSI's $188M market cap.
- Cross-filing context shows an additional $9,170 purchase on July 29, extending the cluster.
Financial Impact
Insider purchase of $88K (0.05% of market cap) — minimal direct financial impact but a positive signal of management confidence.
Risk Factors
- Small dollar amount relative to market cap limits the signal's statistical significance.
- Low trading liquidity in GLSI could amplify price moves on small volume.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| INSIDER-BUY Data (Synthetic) | 0001493152-26-035310 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | DEFA14A | $17.01 | awaiting T+5 | — | $16.83 (−1.08%) |
Oct 26, 2026 today | DEF 14A | $17.28 | awaiting T+5 | — | $16.83 (−2.60%) |
Aug 10, 2026 11w ago | Press Release | $15.50 $17.38 | ▲ +12.13% | ▲ +12.18% | $16.83 (+8.58%) |
Jul 30, 2026 12w ago | Insider Buy | $14.02 $14.24 | ▲ +1.57% | ▼ −2.05% | $16.83 (+20.04%) |
Jul 29, 2026 12w ago | Insider Buy | $12.80 $14.39 | ▲ +12.42% | ▲ +6.89% | $16.83 (+31.48%) |
May 22, 2026 22w ago | Press Release | $27.39 $24.29 | ▲ +11.32% | ▲ +12.53% | $16.83 (+38.55%) |
Apr 22, 2026 26w ago | Press Release | $23.67 $21.60 | ▲ +8.75% | ▲ +10.22% | $16.83 (+28.90%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers